Your Complete Guide to Global Clinical Research and GCP Compliance
Aligning Quality Agreements & SOWs With ICH E6(R3), GCP and Quality-by-Design Principles Aligning Quality Agreements & SOWs With ICH E6(R3), GCP and Quality-by-Design Principles Introduction to Quality Agreements and SOWs in Clinical Trials The implementation of clinical trials is a complex endeavor requiring strict adherence to guidelines and regulations. Central to this process are Quality…
Future-Proofing Quality Agreements & SOWs for AI, Real-World Data and Platform Trials Future-Proofing Quality Agreements & SOWs for AI, Real-World Data and Platform Trials The integration of artificial intelligence, real-world data, and platform trials into clinical research has transformed the landscape of drug development. These advancements demand an evolution of traditional quality agreements and statements…
Read More “Future-Proofing Quality Agreements & SOWs for AI, Real-World Data and Platform Trials” »
Integrating Quality Agreements & SOWs With QMS, Risk Registers and Governance Committees Integrating Quality Agreements & SOWs With QMS, Risk Registers and Governance Committees The clinical trial landscape has rapidly evolved, necessitating enhanced oversight to ensure compliance and efficiency. Quality Agreements (QAs) and Statements of Work (SOWs) play a critical role in defining the expectations…
Case Studies: Quality Agreements & SOWs That Rescued High-Risk Studies and Vendors In the landscape of clinical trials, particularly in high-risk environments, robust frameworks to govern relationships between organizations are critical. This article serves as a step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals focusing on quality agreements and Statements of Work…
Read More “Case Studies: Quality Agreements & SOWs That Rescued High-Risk Studies and Vendors” »
Digital Tools and Automation That Transform Quality Agreements & SOWs in Clinical Development As clinical trials evolve in complexity and scope, the importance of robust quality agreements (QAs) and statements of work (SOWs) becomes increasingly clear. Both documents play critical roles in ensuring compliance, accountability, and clarity in agreements between sponsors and service providers. Digital…
Documenting Quality Agreements & SOWs for Audits, Health Authority Queries and Due Diligence Documenting Quality Agreements & SOWs for Audits, Health Authority Queries and Due Diligence In the realm of clinical research, particularly within the domains governed by the FDA in the United States, the EMA in Europe, and the MHRA in the United Kingdom,…
Performance Management & SLAs Strategies That Strengthen Vendor Oversight and Inspection Readiness Performance Management & SLAs Strategies That Strengthen Vendor Oversight and Inspection Readiness Introduction to Performance Management in Clinical Trials As clinical trials become more complex and the regulatory environment increasingly stringent, the importance of effective performance management in clinical trials cannot be overstated….
Risk-Based Performance Management & SLAs: Reducing Cost Without Losing Quality or Control Risk-Based Performance Management & SLAs: Reducing Cost Without Losing Quality or Control Introduction to Risk-Based Performance Management in Clinical Trials In the realm of clinical trials, particularly for those utilizing the rave clinical trial model, effective risk-based performance management is essential for ensuring…
Performance Management & SLAs in Clinical Trials: Best Practices for US, UK and EU Markets Performance Management & SLAs in Clinical Trials: Best Practices for US, UK and EU Markets In the evolving landscape of clinical trials, effective performance management and service level agreements (SLAs) play a pivotal role in ensuring that studies meet their…
How to Design Performance Management & SLAs for Global GCP-Compliant Clinical Programs In the realm of clinical trials, particularly for large pharmaceutical companies like Astellas, ensuring compliance with Good Clinical Practice (GCP) is paramount. A structured approach to performance management and Service Level Agreements (SLAs) is essential for successful oversight of clinical trials. This tutorial…
Read More “How to Design Performance Management & SLAs for Global GCP-Compliant Clinical Programs” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.